Oncology

Cancer treatments are expected to have a growth rate within the next few years that is twice the average growth rate of the entire pharmaceutical market. In August 2009, approximately 2,000 oncology compounds were in clinical development, with 160 in Phase III trials and 32 in approval pre-registration